Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
---|
02/08/2001 | CA2380007A1 Methods of inhibiting osteoclast activity |
02/08/2001 | CA2377244A1 Computational design methods for making molecular mimetics |
02/08/2001 | CA2376245A1 Binding moieties for fibrin |
02/07/2001 | EP1074842A1 Catalytic anti-factor VIII allo-antibodies |
02/07/2001 | EP1074563A1 Chimeric polypeptides enhancing dimer formation through electrostatic interactions and disulfide bond, method for production and uses thereof |
02/07/2001 | EP1074559A1 Peptide nucleic acids |
02/07/2001 | EP1073891A2 Method of prediciting receptor modulating activity |
02/07/2001 | EP1073744A1 Multifunctional adhesin proteins and their display in microbial cells |
02/07/2001 | EP1073675A1 A process for the conversion of echinocandin class of peptides to their c4-homotyrosine monodeoxy analogues |
02/07/2001 | EP1073454A1 Methods for treating hot flashes and gynaecomastia |
02/07/2001 | EP1073453A1 Methods to increase white blood cell survival after chemotherapy |
02/07/2001 | EP1073451A2 Method for treating ischemia |
02/07/2001 | EP1073447A1 N1-modified glycopeptides |
02/07/2001 | EP0562025B1 Compounds and their use in a binary synthesis strategy |
02/07/2001 | CN1283121A HIV-ITAT or derwatives thereof for prophylatic and therapeutic vacceination |
02/06/2001 | US6184374 Targeted cytotoxic anthracycline analogs |
02/06/2001 | US6184207 A peptide including specified piperidine-containing group, having an n-terminal hydrophobic residue and optionally an amidated c-terminal of specified end groups; treating multiple sclerosis or rheumatoid arthritis |
02/06/2001 | US6184205 Purified peptide of given amino acid sequences that binds to the n-terminal sh3 domain of grb2; useful in modulating signal transduction pathways at the cellular level, in modulating oncogenic protein activity |
02/06/2001 | US6184204 Peptides suitable for use in antigen specific immunosuppressive therapy |
02/06/2001 | US6184200 Truncated glial cell line-derived neurotrophic factor |
02/06/2001 | US6184025 Nucleotide sequences for the detection and diagnosis of viral diseases |
02/06/2001 | US6183992 Recombinant production by constructing and using expression vector having fusion gene coding for negatively charged acidic peptide with two cysteines and positively charged basic antimicrobial peptide; minimizes effect of microbiocide |
02/06/2001 | US6183949 HCV peptide antigens and methods for the determination of HCV |
02/06/2001 | US6183736 Small peptides with antipathogenic activity, treated plants and methods for treating same |
02/06/2001 | US6183721 A radioactive cyclic octapeptides for radiotherapy of somatostatin receptor positive tumors; antitumor agents |
02/06/2001 | CA2172144C Hapten-marked peptides |
02/06/2001 | CA2155872C Oxytocin antagonist |
02/06/2001 | CA2106299C Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
02/06/2001 | CA2013544C Retinoblastoma gene product antibodies and uses therefor |
02/01/2001 | WO2001007918A1 Catalytic anti-factor viii allo-antibodies |
02/01/2001 | WO2001007477A1 Vgf polypeptides and methods of treating vgf-related disorders |
02/01/2001 | WO2001007474A1 Peptides containing n-substituted d-amino acids for preventing beta-strand association |
02/01/2001 | WO2001007473A1 Peptides containing n-substituted l-amino acids for preventing beta-strand association |
02/01/2001 | WO2001007468A2 Novel cyclohexapeptide compounds, processes for their production and their use as a pharmaceutical |
02/01/2001 | WO2001007467A1 Streptogramin derivatives, preparation and compositions containing same |
02/01/2001 | CA2380176A1 Novel cyclohexapeptide compounds, processes for their production and their use as a pharmaceutical |
02/01/2001 | CA2380037A1 Vgf polypeptides and methods of treating vgf-related disorders |
02/01/2001 | CA2379818A1 Catalytic anti-factor viii allo-antibodies |
02/01/2001 | CA2379241A1 Peptides containing n-substituted d-amino acids for preventing beta-strand association |
02/01/2001 | CA2378779A1 Peptides containing n-substituted l-amino acids for preventing beta-strand association |
01/31/2001 | EP1071705A2 Peptides causing formation of compact structures |
01/31/2001 | EP1071704A1 Novel matrix metalloproteinase inhibitors and down-regulators |
01/31/2001 | EP1071443A1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof |
01/31/2001 | EP1071442A1 Methods and compositions for peptide synthesis |
01/31/2001 | CN1282337A Cyclopeptide derivatives with integrin inhibitor properties |
01/31/2001 | CN1282253A Small peptides and method for treatment of asthma and inflammation |
01/30/2001 | US6180604 Compositions and methods for treating infections using analogues of indolicidin |
01/30/2001 | US6180085 Useful for optical tomographic, endoscopic, photoacoustic and sonofluoresence applications for detection and treatment of tumors and other abnormalities |
01/30/2001 | CA2177604C Labelling of nucleic acid analogue-peptide chimerae |
01/30/2001 | CA2124458C Technetium-99m labeled peptides for imaging |
01/30/2001 | CA2101942C Technetium-99m labeled polypeptides for imaging |
01/25/2001 | WO2001005819A1 Novel water soluble-cyclosporine conjugated compounds |
01/25/2001 | WO2001005818A1 Novel water soluble-cyclosporin conjugated compounds |
01/25/2001 | WO2001005817A1 Pseudomycin amide and ester analogs |
01/25/2001 | WO2001005816A1 Amine-modified pseudomycin compounds |
01/25/2001 | WO2001005815A1 Process for deacylation of lipodepsipeptides |
01/25/2001 | WO2001005814A1 Pseudomycin n-acyl side-chain analogs |
01/25/2001 | WO2001005813A1 Pseudomycin prodrugs |
01/25/2001 | WO2001005811A2 Cyclic peptidomimetic urokinase receptor antagonists |
01/25/2001 | WO2001005810A2 CYCLIC PEPTIDE DERIVATIVES AS INHIBITORS OF INTEGRIN αVβ¿6? |
01/25/2001 | WO2001005757A2 Process for the deprotection of protected thiols |
01/25/2001 | WO2000066587A3 Polyamines and their use in therapy |
01/25/2001 | DE19933701A1 Zyklische peptidomimetische Urokinaserezeptorantagonisten Cyclic peptidomimetic Urokinaserezeptorantagonisten |
01/25/2001 | CA2616565A1 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
01/25/2001 | CA2379851A1 Pseudomycin n-acyl side-chain analogs |
01/25/2001 | CA2379321A1 Pseudomycin amide and ester analogs |
01/25/2001 | CA2379317A1 Amine-modified pseudomycin compounds |
01/25/2001 | CA2379058A1 Pseudomycin prodrugs |
01/25/2001 | CA2379022A1 Cyclic peptide derivatives as inhibitors of integrin .alpha.v.beta.6 |
01/25/2001 | CA2378868A1 Process for deacylation of lipodepsipeptides |
01/24/2001 | EP1070727A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
01/24/2001 | EP1070254A1 Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions |
01/24/2001 | EP1069906A1 Conjugates useful in the treatment of prostrate cancer |
01/23/2001 | US6177554 Nucleic acid transporter systems |
01/23/2001 | US6177407 Specifically ischemic cardiac tissue, by administering at least one of angiotensinogen and specified sequences encoding angiotensin i, its analogues and fragments, angiotensin ii (aii) analogues or fragments, and aii at2 type 2 receptor |
01/23/2001 | US6177405 Cyclic analogs of tuftsin |
01/23/2001 | US6177253 Screening methods for the identification of anti-HIV compounds employing a cyclosporine-specific monoclonal antibody that cross-reacts with HIV-1 p24 |
01/18/2001 | DE19933173A1 Cyclische Peptidderivate als Inhibitoren des Integrins alpha¶v¶beta¶6¶ Cyclic peptide derivatives as inhibitors of the integrin alpha¶v¶beta¶6¶ |
01/17/2001 | EP1069137A1 Peptides having thrombospondin-like activity and their therapeutic use |
01/17/2001 | EP1068757A2 A method for controlling connections to a mobile station |
01/17/2001 | EP1068331A1 Medicaments for inducing cytotoxic t-cells |
01/17/2001 | EP1068313A2 Collagen peptides and uses thereof |
01/17/2001 | EP1068307A1 Secreted proteins and polynucleotides encoding them |
01/17/2001 | EP1068303A2 Assay for the diagnosis of schizophrenia based on a new peptide |
01/17/2001 | EP1068224A2 Pharmaceuticals for the imaging of angiogenic disorders |
01/17/2001 | EP1068223A1 Calcium salts of lipopeptide antibiotics, method for producing same and their use |
01/17/2001 | EP1068222A1 Radiopharmaceuticals for imaging infection and inflammation and for imaging and treatment of cancer |
01/17/2001 | EP1068221A2 Template associated npy y2-receptor agonists |
01/17/2001 | EP1067952A1 Methods for treatment and prevention of infections |
01/17/2001 | EP1067950A1 Neo-tryptophan |
01/17/2001 | EP1067949A1 Sequence and method for genetic engineering of proteins with cell membrane translocating activity |
01/17/2001 | CN1280501A Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
01/16/2001 | US6174993 Short peptides which selectively modulate the activity of serine/threonine kinases |
01/16/2001 | US6174862 Neuroprotectant administered to patients suffering from alzheimer's disease, human immunodeficiency virus |
01/16/2001 | US6174691 Deactivating a preferential tumor glycoprotein or a cell expressing preferential glycoprotein; exposing preferential glycoprotein or cell expressing the preferential glycoprotein to a toxic substance |
01/16/2001 | US6174687 Methods of identifying lung homing molecules using membrane dipeptidase |
01/16/2001 | US6174528 Inducing protective antibodies against group a streptococci |
01/16/2001 | CA2200192C Amidino and guanidino substituted inhibitors of trypsin-like enzymes |
01/16/2001 | CA2164707C Technetium-99m labeled peptides for imaging inflammation |
01/16/2001 | CA2068324C Metal-peptide compositions and methods for stimulating hair growth |